Calcium channel blockers enhance cholesteryl ester hydrolysis and decrease total cholesterol accumulation in human aortic tissue

« Previous Article | Table of Contents | Next Article »

Circulation Research. 1990;66:185-190

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager
	Request Permissions

Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Etingin, O. R.
	Articles by Hajjar, D. P.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Etingin, O. R.
	Articles by Hajjar, D. P.

ARTICLES

Calcium channel blockers enhance cholesteryl ester hydrolysis and decrease total cholesterol accumulation in human aortic tissue

OR Etingin and DP Hajjar
Department of Medicine Hematology-Oncology, Cornell University Medical College, New York, NY 10021.

Calcium channel blockers (CCBs), which are used clinically for treatment of angina and hypertension, are known to inhibit calcium influx into arterial smooth muscle cells and thereby decrease smooth muscle cell contraction. In addition, they prevent cholesteryl ester (CE) accumulation, the hallmark of human atherosclerosis, in arteries of cholesterol-fed animals by cellular mechanisms that remain undefined. To assess whether CCBs enhance CE hydrolysis and reduce CE accumulation in human arterial cells, we measured activities of the CE metabolic cycle in aortic tissues that were stripped of endothelial cells and adventitia from 35 patients undergoing coronary artery bypass surgery. Patients who were treated with either nifedipine or diltiazem (n = 23) for several months demonstrated a threefold increase in arterial CE hydrolytic activities compared with untreated patients. This difference was independent of serum cholesterol levels, age, or treatment with other medications. No effects were observed on CE synthetic activity. Cyclic AMP levels in the aortic tissue of patients treated with CCBs were also significantly elevated twofold to threefold. In addition, both free and esterified cholesterol were significantly reduced in aortic tissue from patients taking CCBs compared with untreated patients. These data are the first to show that CCBs can increase CE hydrolysis in human aortic tissue by increasing intracellular cyclic AMP with resultant decrease in CE accumulation. Collectively, these findings support the hypothesis that CCBs can act as antiatherosclerotic agents in human tissue by mobilizing stored CE in the arterial wall.

This article has been cited by other articles:

P. Lesnik, C. Dachet, L. Petit, M. Moreau, S. Griglio, P. Brudi, and M. J. Chapman
Impact of a Combination of a Calcium Antagonist and a �-Blocker on Cell- and Copper-Mediated Oxidation of LDL and on the Accumulation and Efflux of Cholesterol in Human Macrophages and Murine J774 Cells
Arterioscler Thromb Vasc Biol, May 1, 1997; 17(5): 979 - 988.
[Abstract] [Full Text]

J. W. Jukema, A. H. Zwinderman, A. J. van Boven, J. H.C. Reiber, A. Van der Laarse, K. I. Lie, and A. V.G. Bruschke
Evidence for a Synergistic Effect of Calcium Channel Blockers With Lipid-Lowering Therapy in Retarding Progression of Coronary Atherosclerosis in Symptomatic Patients With Normal to Moderately Raised Cholesterol Levels
Arterioscler Thromb Vasc Biol, March 1, 1996; 16(3): 425 - 430.
[Abstract] [Full Text]

				J. W. Jukema, A. H. Zwinderman, A. J. van Boven, J. H.C. Reiber, A. Van der Laarse, K. I. Lie, and A. V.G. Bruschke Evidence for a Synergistic Effect of Calcium Channel Blockers With Lipid-Lowering Therapy in Retarding Progression of Coronary Atherosclerosis in Symptomatic Patients With Normal to Moderately Raised Cholesterol Levels Arterioscler Thromb Vasc Biol, March 1, 1996; 16(3): 425 - 430. [Abstract] [Full Text]